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Changes in nuclear size and shape during the cell cycle or
during development require coordinated nuclear membrane
remodeling, but the underlying molecular events are largely
unknown. We have shown previously that the activity of the
conserved phosphatidate phosphatase Pah1p/Smp2p regulates
nuclear structure in yeast by controlling phospholipid synthesis
andmembrane biogenesis at the nuclear envelope. Two screens
for novel regulators of phosphatidate led to the identification of
DGK1. We show that Dgk1p is a unique diacylglycerol kinase
that uses CTP, instead of ATP, to generate phosphatidate.
DGK1 counteracts the activity of PAH1 at the nuclear envelope
by controlling phosphatidate levels. Overexpression of DGK1
causes the appearance of phosphatidate-enriched membranes
around the nucleus and leads to its expansion, without prolifer-
ating the cortical endoplasmic reticulummembrane.Mutations
that decrease phosphatidate levels decrease nuclear membrane
growth in pah1 cells.We propose that phosphatidate metabo-
lism is a critical factor determining nuclear structure by regulat-
ing nuclear membrane biogenesis.
Phospholipids are the major cellular components required
for the assembly of biological membranes (1). The regulated
production and distribution of phospholipids during the cell
cycle or during development often underlie striking changes in
membrane biogenesis, which, in turn, can impact on the size,
shape, or number of organelles. For example, stimulation of
phospholipid biosynthesis accompanies the expansion of the
ER3 in professional secretory cells (2) or neurite growth during
neuronal differentiation (3). Despite these interesting observa-
tions, the molecular mechanisms responsible for coupling lipid
production to organelle morphology remain largely unknown.
An organelle that undergoes striking structural changes dur-
ing the cell cycle is the nucleus. The nucleus is delimited by the
nuclear envelope, which consists of a double lipid bilayer, the
outer and inner nuclear membranes (4). The outer membrane
is continuous with the ER, whereas the inner membrane faces
the nucleoplasm and binds to chromatin. Nuclear membrane
growth is essential for cell division. In yeast, nuclear membrane
expansion allows anaphase to take place within a single nuclear
compartment that partitions between mother and daughter
cells (5). In metazoan cells, the nuclear membrane expands at
the end of mitosis to accommodate chromatin decondensation
and DNA replication (6). The source of the nuclear membrane
and themechanismbywhich it is added to the nuclear envelope
remain unknown. Nuclear envelope remodeling is also impor-
tant for cell types that undergo dramatic nuclear structure
changes during their differentiation, such as mammalian blood
cell types, where nuclei can be highly lobed and segmented, or
spermatocytes and myocytes, where nuclei can take very elon-
gated morphologies (7). The importance of proper nuclear
envelope structure in cell physiology is underscored by the
recent identification of several diseases that are associated with
changes in nuclear shape and are caused by mutations in
nuclear envelope proteins (8).
We have recently identified an unexpected link between
phospholipid biosynthesis and nuclear structure. Mutations in
Pah1p, a PA phosphatase that catalyzes the dephosphorylation
of PA to DAG (9), cause proliferation of the nuclear/ER mem-
brane and a massive expansion of the nucleus (10). Interest-
ingly, the activity of Pah1p is regulated by Cdc28p-dependent
phosphorylation duringmitosis. A phosphorylation-null Pah1p
mutant has higher PA phosphatase activity than the wild-type
enzyme (11). Consistent with this, cells lacking Nem1p-Spo7p,
the phosphatase complex that dephosphorylates Pah1p, accu-
mulate hyperphosphorylated Pah1p and exhibit nuclear mem-
brane proliferation like pah1 cells (10).
There are two key consequences of the changes in PA levels
that take place in pah1 mutants. First, in yeast cells, PA regu-
lates coordinately the transcription of many phospholipid bio-
synthetic enzyme genes through the PA-sensitive repressor
Opi1p (12).When levels of PA are high, as inpah1 cells,Opi1p
is excluded from the nucleus, and transcription is derepressed
(13). Interestingly, Pah1p regulates the transcription of these
genes through both Opi1p-dependent and Opi1p-independent
mechanisms (11). Second, both PA andDAGare the precursors
for the synthesis of abundant phospholipids that are used for
membrane biogenesis, through the CDP-DAG and CDP-cho-
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line pathways, respectively (see Fig. 1A). Therefore, changes in
PA and DAG levels in pah1 mutants impact on the cellular
levels of these phospholipids (9, 14).
How the inactivation of Pah1p leads to nuclear growth is not
understood. Moreover, whether Pah1p regulates primarily ER
or nuclear membrane biogenesis and whether particular lipids
are associated with these changes are not known. We have
shown previously that the up-regulation of phospholipid syn-
thesis is necessary but not sufficient to drive nuclear growth in
pah1 cells (10, 11). Therefore, there could be additional fac-
tors required for nuclear expansion. To investigate the role of
phospholipid biosynthesis in nuclearmembrane formation and
to identify novel components involved in this process, we
applied two complementary genetic approaches. First, a sys-
tematic search among mutants of known phospholipid biosyn-
thetic enzymes revealed that only Pah1p affects nuclear struc-
ture. We therefore performed two non-biased screens looking
for previously uncharacterized genes that could encode PA reg-
ulators and examined their effect on nuclear structure. Both
screens identified the same gene, DGK1 (known previously as
HSD1), encoding a nuclear/ER integral membrane protein.We
show thatDgk1p counteracts the effects of Pah1p at the nuclear
membrane by controlling PA levels. Dgk1p is a novel CTP-de-
pendent DAG kinase that catalyzes the phosphorylation of
DAG to PA. Unlike previously described DAG kinases that use
ATP, Dgk1p utilizes CTP as a phosphate donor for the kinase
reaction. Overexpression of DGK1 causes recruitment of PA
reporter protein on the nuclear membrane and leads to its
expansion. Interestingly, cortical ER membrane is not prolifer-
ating in these cells. These data reveal a specific role for PA
metabolism in nuclear membrane biogenesis.
EXPERIMENTAL PROCEDURES
Yeast Strains, Media, and Growth Conditions—The yeast
strains used in this study are listed in Table 1. Unless stated
otherwise, the deletion mutants shown in Fig. 1 were obtained
fromOpen Biosystems and are derived from the BY4742 strain.
Knock-out of DGK1 was done by homologous recombination,
transforming a dgk1::HIS3 fragment containing 5- and
3-flanking sequences into the wild-type (RS453) or
pah1::TRP1 deletion strain to obtain the dgk1 or pah1dgk1
strains, respectively. Deletion of other genes (GAT1, GAT2,
PSD1, CHO2, and OPI3) into the pah1 strain was done by
transforming the appropriate KanMX4 fragments into a
pah1::TRP1 strain complemented by a YCplac33-PAH1 plas-
mid. The PAH1 plasmid was then shuffled out on 5-fluoroo-
rotic acid-containing plates to yield the appropriate double
deletions. Yeast cells were grown in YEPD (1% yeast extract, 2%
peptone, and 2% glucose) or synthetic medium containing 2%
glucose and lacking the appropriate amino acids for plasmid
selection. GAL1/10-dependent overexpression was performed
by changing the carbon source of early log phase cells from 2%
raffinose to 2% galactose. Cells were grown at 30 °C unlessmen-
tioned otherwise. To assay growth of yeast cells in medium
lacking inositol, synthetic medium was prepared using yeast
nitrogen base lacking inositol (Bio 101, Inc.).
Plasmids and Construction of Fusion Genes—The plasmids
used in this study are listed in Table 2. The high copy library
used for the suppressor screens was from American Type Cul-
ture Collection (catalog no. 37323). The construction of
GAT2(G253L) and DGK1(D177A) was done by PCR-mediated
mutagenesis. The wild-type DGK1 and DGK1(D177A) genes
TABLE 1
Yeast strains used in this study
Strain Genotype Ref./source
RS453 MATa ade2-1 his3-11,15 ura3-52 leu2-3,112 trp1-1 Ref. 43
SS1026 RS453 pah1::TRP1 Ref. 10
SS1144 RS453 dgk1::HIS3 This study
SS1147 RS453 pah1::TRP1 dgk1::HIS3 This study
SS1246 RS453 pah1::TRP1 gat1::KanMX4 This study
SS1247 RS453 pah1::TRP1 gat2::KanMX4 This study
SS1282 RS453 pah1::TRP1 psd1::KanMX4 YCplac33-URA3-PAH1 This study
SS1301 RS453 pah1::TRP1 cho2::KanMX4 YCplac33-URA3-PAH1 This study
SS1290 RS453 pah1::TRP1 opi3::KanMX4 YCplac33-URA3-PAH1 This study
SS1372 RS453 mCherry-PUS1::URA3 This study
TABLE 2
Plasmids used in this study
Plasmid Description Ref./source
YCplac111-SEC63-GFP SEC63-GFP under control of SEC63 promoter into CEN/LEU2 vector Ref. 10
YCplac33-SEC63-GFP SEC63-GFP under control of SEC63 promoter into CEN/URA3 vector This study
YEplac195-PAH1-7P PAH1-7P under control of GAL1/10 promoter into 2/URA3 vector This study
YCplac33-GAL1/10-NEM1 NEM1 under control of GAL1/10 promoter into CEN/URA3 vector This study
pRS313-GAL1/10-SPO7 SPO7 under control of GAL1/10 promoter into CEN/HIS3 vector This study
YCplac111-GAL1/10-DGK1 DGK1 under control of GAL1/10 promoter into CEN/LEU2 vector This study
YEplac181-GAL1/10-DGK1 DGK1 under control of GAL1/10 promoter into 2/LEU2 vector This study
pRS313-RFP-PUS1 PUS1 under control of NOP1 promoter into CEN/HIS3 vector This study
YCplac111-GAL1/10-DGK1(D177A) DGK1(D177A) under control of GAL1/10 promoter into CEN/LEU2 vector This study
YIplac211-mCherry-PUS1 PUS1 under control of NOP1 promoter into integrative/URA3 vector This study
YCplac33-RTN2-GFP RTN2-GFP under control of RTN2 promoter into CEN/URA3 vector This study
YCplac111-HEH2-GFP HEH2-GFP under control of NOP1 promoter into CEN/LEU2 vector This study
YCplac33-PAH1 PAH1 under control of PAH1 promoter into CEN/URA3 vector Ref. 10
pRS426-G20 GFP-SPO20-(51–91) under control of TEF2 promoter into 2/URA3 vector Ref. 26
pRS424-GAL1pr-DGK Bacterial DGK under control of GAL1 promoter into 2/TRP1 vector Ref. 26
YCplac111-GAT2 GAT2 under control of GAT2 promoter into CEN/LEU2 vector This study
YCplac111-GAT2(G253L) GAT2(G253L) under control of GAT2 promoter into CEN/LEU2 vector This study
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were overexpressed using the GAL1/10 promoter. The RTN2-
GFP fusionwas constructed by inserting theGFP fragment into
the C terminus of RTN2. The fusion gene was cloned into a
centromeric URA3 vector (YCplac33), and its expression was
driven by the RTN2 promoter. TheHEH2-GFP fusion was con-
structed by inserting the GFP fragment into the C terminus of
HEH2. The fusion gene was cloned into a centromeric LEU2
vector (YCplac111), and its expression was driven by theNOP1
promoter. The mCherry-PUS1 fusion was constructed by
introducing the mCherry fragment into the N terminus of
PUS1. The fusion gene was cloned into a YIplac211 vector, and
its expression was driven by the NOP1 promoter. The PtA-
DGK1 and GFP-DGK1 fusions were constructed by inserting
the protein A or GFP fragment, respectively, into the N termi-
nus of DGK1; their expression was driven by the NOP1 or
DGK1 promoter, respectively. The DGK1-PtA fusion was con-
structed by inserting the protein A fragment into the C termi-
nus of DGK1, and its expression was driven by inducible
GAL1/10 promoter.
High Copy Number Suppressor Screens—For the PAH1-7P
suppressor screen, the wild-type RS453 strain overexpressing
PAH1-7P from the inducibleGAL1/10 promoter in a high copy
plasmid (YEplac195) was transformed with a high copy yeast
genomic library (15). About 5000 transformants were screened
for their ability to suppress the toxicity of the overexpressed
PAH1-7P mutant on galactose plates lacking inositol (11).
Library plasmids were recovered from two suppressor colonies
and then retransformed into the original screening strain to
verify the suppression. Sequencing of the two library plasmids
followed by subcloning of various open reading frames present
in the genomic fragment showed that, in both cases, the DGK1
gene was responsible for the suppression of the inositol auxot-
rophy of the PAH1-7P mutant.
For theNEM1-SPO7 suppressor screen, the wild-type RS453
strain overexpressingNEM1 and SPO7 from theGAL1/10 pro-
moter in the YCplac33 and pRS313 plasmids, respectively, was
transformed with the same high copy genomic library as
described above. About 6000 transformants were screened for
their ability to suppress the toxicity of the NEM1-SPO7 over-
expression (10). Four suppressors were isolated that were
found, when analyzed as described above, to contain overlap-
ping inserts of the DGK1 gene. Further subcloning demon-
strated that DGK1 was responsible for the suppression of the
NEM1-SPO7 toxicity.
RNA Extractions and Quantitative PCR—Total RNA was
isolated as described previously (11). Quantitative real-time
PCRwas performed on total RNAusing anABI 7900HT system
and a SYBR Green Mastermix (Applied Biosystems) as
described previously (11).
Affinity Purification of PtA-Dgk1p—The dgk1 strain carry-
ing a pRS315-PtA-DGK1 fusion was grown toA600 1, washed
once with water, and spheroplasted as described previously
(16). Spheroplasts were first lysed in 150 mM KCl, 20 mM Tris-
HCl (pH 8.0), and 5mMMgCl2 supplemented with amixture of
protease inhibitors (Complete EDTA-free, Roche Applied Sci-
ence) and 4-(2-aminoethyl)benzenesulfonyl fluoride. The
extract was centrifuged for 15 min at 15,000 rpm (Sorvall SS34
rotor), and the pellet was resuspended in the same lysis buffer
containing 1%TritonX-100. The extract was centrifuged for 30
min as described above, and the supernatant was first pre-
cleared by incubation with Sepharose Fast-Flow beads (GE
Healthcare) and then loaded onto a column packed with IgG-
Sepharose beads (GEHealthcare). Affinity purifications of PtA-
Dgk1p followed by tobacco etch virus protease-dependent elu-
tion of untagged Dgk1p were performed as described (16).
Preparation of Labeled CTP—[-32P]CTP was synthesized
enzymatically from CDP and [-32P]ATP with nucleoside-
diphosphate kinase as described previously (17).
DAG Kinase Assay—DAG kinase activity was measured for
20 min by following the phosphorylation of 0.1 mM DAG with
0.1 mM [-32P]CTP (50,000 cpm/nmol) in the presence of 50
mMTris-HCl (pH 7.5), 1 mMTriton X-100, 5 mMCaCl2, 10 mM
-mercaptoethanol, and enzyme protein in a total volume of
0.1mM at 30 °C. The reaction was terminated by the addition of
0.5 ml of 0.1 N HCl in methanol. The radioactive chloroform-
soluble product PA was separated from the radioactive water-
soluble substrate CTP by a chloroform/methanol/water phase
partition (18). The radioactive chloroform phase was subjected
to liquid scintillation counting. Alternatively, the product
was subjected to thin layer chromatography using a solvent
system of chloroform/methanol/water (65:25:4, v/v) and
visualized by phosphorimaging. The DAG kinase assay was
conducted in triplicate, and the average S.D. of the assay was
5%. The enzyme reaction was linear with time and protein
concentration.
Labeling and Analysis of Lipids—Steady-state labeling of
phospholipids and neutral lipids with 32Pi and [2-14C]acetate,
respectively, was performed as described previously (9). Phos-
pholipids were separated by two-dimensional thin layer chro-
matography on silica gel plates using chloroform/methanol/
ammonium hydroxide/water (45:25:2:3, v/v) and chloroform/
methanol/glacial acetic acid/water (32:4:5:1, v/v) as the solvent
systems for the first and second dimensions, respectively. Neu-
tral lipids were separated by one-dimensional thin layer chro-
matography on silica gel plates using a solvent system of hex-
ane/diethyl ether/glacial acetic acid (40:10:1, v/v). The identity
of the labeled lipids on thin layer chromatography plates was
confirmed by comparison with standards after exposure to
iodine vapor. Radiolabeled lipids were visualized by phospho-
rimaging and subjected to ImageQuant analysis.
Microscopy—To visualize GFP, red fluorescent protein, and
mCherry fusions, cells were grown in the appropriate selective
medium at 30 °C to early logarithmic phase and examined with
a 63 Plan Apochromat objective on a Zeiss Axiovert 200 M
inverted microscope with an LSM 510 confocal laser scanning
attachment. Cells in Figs. 2D and 6C were viewed using a Zeiss
Axiophot fluorescence microscope equipped with a CCD cam-
era, and images were recorded using IP Labs software.
Antibodies—The antibody used to detect protein A fusions
was from DAKO (catalog no. Z0113).
RESULTS
Systematic Analysis of the Function of Phospholipid Bio-
synthetic Enzymes in Nuclear Structure—Pah1p is a con-
served Mg2-dependent PA phosphatase required for phos-
pholipid and triacylglycerol synthesis (9). Inactivation of
Regulation of Nuclear Structure by Dgk1p
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Pah1p leads to changes in PA and phospholipid levels (9) and
results in a massive expansion of the nuclear/ER membrane
(10). To address the possible role of distinct lipid species in
nuclear structure, we first asked whether inhibition of other
phospholipid biosynthetic steps could have a similar effect
on the nuclear/ER membrane. Using a SEC63-GFP fusion as
a reporter, we analyzed nuclear/ER membrane structure in a
series of mutants lacking the enzymes catalyzing key steps in
PA, phosphatidylinositol, phosphatidylserine, PE, and PC
biosynthesis (highlighted in Fig. 1A). Partial defects in
peripheral ER structure were observed in cells lacking Cho2p
and Opi3p, involved in the final steps of PCmethylation (Fig.
1C). Depletion of Cds1p, the essential cytidylyltransferase
that utilizes PA to synthesize phospholipids via the CDP-
DAG pathway, also partially affects cortical ER structure
(Fig. 1C). However, nuclear membrane proliferation and
nuclear expansion, similar to those seen in pah1 cells, were
not observed in any of the mutants tested. Therefore, among
the different phospholipid biosynthetic steps, the Pah1p-
mediated dephosphorylation of PA to DAG plays a unique
role in nuclear structure.
Genetic Screens for Factors Regulating PA Metabolism Iden-
tify Dgk1p—We reasoned that, if PA regulates nuclear/ER
membrane biogenesis, then the activity of other proteins that
control PA levels might also impact on nuclear/ER structure.
We therefore undertook two screens to identify novel genes
encoding PA regulators. Both screens are based on our previous
finding that the PA phosphatase activity of Pah1p, which con-
trols cellular concentration of PA (9), is inhibited by phospho-
rylation (11). Expression of constitutively dephosphorylated
Pah1p, generated by mutating its phosphorylation sites
(PAH1-7P mutant), increases its PA phosphatase activity,
represses transcription of phospholipid biosynthetic enzymes,
and results in lethality in medium lacking inositol (11). This
phenotype is consistent with a decrease in cellular PA levels.
Similarly, overexpression of the Nem1p-Spo7p phosphatase
complex, which dephosphorylates Pah1p, is also lethal (10).We
therefore screened for high copy number suppressors that can
rescue the lethality of the overexpression of PAH1-7P (screen I)
or theNEM1-SPO7 phosphatase (screen II). Both screens iden-
tified independently the same gene, DGK1 (known previously
as HSD1). The suppression of the PAH1-7P and NEM1-SPO7
lethality was confirmed by overexpressingDGK1 in the respec-
tive strains using the inducible GAL1/10 promoter (Fig. 2, A
and B, respectively). DGK1/HSD1 was originally isolated in a
screen for suppressors of a sly1mutant involved in ER-to-Golgi
trafficking (19), but its function andmechanism of suppression
remained so far unknown. Its gene product, Dgk1p, is a 32.8-
kDa protein that consists of a short N-terminal hydrophilic
region (residues 1–73) followed by four putative transmem-
brane domains containing a predicted cytidylyltransferase
domain (residues 74–288) (Fig. 2C). BLAST searches identified
putative Dgk1p orthologs in several other yeast species, but not
any apparent related proteins in higher eukaryotes.4 A GFP-
4 S. Siniossoglou, unpublished data.
FIGURE 1. Systematic analysis of the role of phospholipid metabolism in
nuclear/ERmembrane structure.A, pathways of phospholipid biosynthesis
andPAmetabolism inbudding yeast. Reactions involved in theproduction of
cellular pools of phospholipids are shown. For simplicity, the Kennedy path-
way reactions leading to PE synthesis are not shown. Blue and red arrows
highlight the CDP-DAG and CDP-choline (Cho) pathways, respectively. G3P,
glycerol 3-phosphate; DHAP, dihydroxyacetone phosphate. LPA, lysophos-
phatidic acid; PI, phosphatidylinositol; PS, phosphatidylserine. B, list of
mutants tested for nuclear/ER morphology defects. Cells were transformed
with a centromeric plasmid expressing SEC63-GFP and visualized by micros-
copy. At least two transformants per mutant were analyzed., no defects in
nuclear or ER structure;, severe defects;/, partial defects. The tet-CDS1
repressible strain was grown in the presence of 10 g/ml doxycycline, and
SEC63-GFP fluorescence was visualized after 0, 6, 12, and 24 h. The pis1 tem-
perature-sensitive strain was grown at 30 °C and then transferred to 37 °C for
3 h. All mutants were derived from BY4742, except the tet-CDS1 and psd1
strains, which were derived from BY4741, and the pis1 (41) and pah1 (10)
strains. C, representative images of wild-type, tet-CDS1 (12 h in doxycycline),
and opi3 expressing the SEC63-GFP reporter. Scale bar 5 m.
FIGURE 2.DGK1 rescues the lethality of dephosphorylated PAH1. A, iden-
tification of DGK1 as a high copy suppressor of the inositol auxotrophy of
PAH1-7P. The wild-type RS453 strain carrying a high copy vector expressing
the non-phosphorylated PAH1-7P mutant from a galactose-inducible pro-
moter was transformed with the indicated plasmids. Transformants were
grown on synthetic plates lacking inositol and supplemented with glucose
(left panel) or galactose (right panel) at 30 °C.B, identificationofDGK1 as ahigh
copy suppressor of the lethality of NEM1-SPO7 overexpression. RS453 cells
carrying plasmids coexpressing NEM1 and SPO7 from a galactose-inducible
promoterwere transformedwith the indicatedplasmids. Transformantswere
grown on synthetic plates supplemented with glucose (left panel) or galac-
tose (right panel) at 30 °C. C, primary structure and hydropathy plot of Dgk1p.
The gray box indicates the conserved cytidylyltransferase domain within
Dgk1p. Below, the hydropathy plot of Dgk1p is given (42), using a window of
19 amino acids. The black lines indicate the positions of the predicted trans-
membrane domains.D, GFP-Dgk1p localizes to the nuclear membrane and
ER. A GFP-DGK1 fusion under the control of the DGK1 promoter was
expressed from a centromeric plasmid in a dgk1 strain. Cells were grown
in early logarithmic phase and visualized by fluorescent microscopy. Scale
bar 5 m.
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Dgk1p fusion, expressed under the control of the endogenous
DGK1 promoter, localized to the ER and nuclear membrane
(Fig. 2D).
Dgk1p Counteracts the Function of Pah1p by Controlling
PA Levels—Cells lacking DGK1 show no apparent growth
defects or gross nuclear/ER structure abnormalities.4 Given
that NEM1-SPO7 overexpression inhibits nuclear expansion
during mitosis (10) and that a previous study reported the
appearance of membranous tubules in DGK1-overexpress-
ing cells (19), we first asked whether high levels of DGK1
could rescue the lethality of theNEM1-SPO7 overexpression
by promoting nuclear growth. Indeed, wild-type cells over-
expressing DGK1 from a galactose-inducible promoter con-
tain enlarged and irregularly shaped nuclei and a striking
nuclear/ER membrane proliferation that is reminiscent of
that originally observed in cells lacking PAH1 (Fig. 3A).
Because the overproduction of DGK1 phenocopies the mor-
phological defects of pah1 cells, we next asked whether the
complementary possibility would be true, i.e.whether lack of
DGK1would rescue the nuclear expansion that takes place in
pah1 cells. Although pah1 dgk1 cells are still tempera-
ture-sensitive,4 they have normal nuclear morphology in
that the nuclear/ERmembrane labeling by SEC63-GFP looks
identical to that of wild-type cells (Fig. 3B). Therefore, the
function of Dgk1p in the nuclear structure appears to coun-
teract that of Pah1p.
Because the accumulation of PA contributes to the transcrip-
tional up-regulation of phospholipid biosynthetic genes and to
the increased membrane biogenesis in pah1 cells, we next
askedwhether the lack ofDGK1 rescues the nuclearmembrane
proliferation of pah1 cells by affecting cellular PA levels. To
test this hypothesis, we compared the phospholipid composi-
tion of pah1 dgk1 cells with that of the corresponding single
mutants andwild-type strain. Indeed, deletion ofDGK1 returns
the PA levels of the pah1 cells to normal (Fig. 4A). Consistent
with this,mRNA levels of INO1 that respond to the intracellular
PA concentration (13) are brought back to their respective
wild-type values (Fig. 4C). The levels of PE in pah1 dgk1 are
also brought back to normal, whereas the levels of PC are par-
tially corrected. However, the abnormal phosphatidylinositol
(Fig. 4A) and major neutral lipid triacylglycerol (Fig. 4B) levels
of the pah1mutant are not affected by the deletion of DGK1.
Taken together, these data show that the function of DGK1 in
the nuclearmembrane counteracts that of PAH1 by controlling
cellular PA levels.
Dgk1p Is a Novel CTP-dependent DAGKinase—The fact that
the dgk1mutation returns cellular PA levels in pah1 cells to
normal raised the possibility that the activity of Dgk1pmight be
directly involved in the synthesis of PA. The cytidylyltrans-
ferase domain present in Dgk1p shows significant similarity to
the PA cytidylyltransferase Cds1p (also known as CDP-DAG
synthase), the enzyme that synthesizes CDP-DAG from CTP
and PA. Cds1p can also catalyze the reverse reaction that leads
to PA synthesis (20, 21). To investigate whether DGK1 can
function as a CDP-DAG synthase, we asked whether (a) over-
expression of DGK1 could rescue a conditional CDS1 mutant
and (b) overexpression of CDS1 could rescue, like DGK1, the
toxicity of PAH1-7P. In both cases, the results were negative.4
Taken together, these data suggest that Dgk1p does not func-
tion as a CDP-DAG synthase in vivo.
A second reaction that can directly generate PA is the
phosphorylation of DAG. Although there is no homolog in
Saccharomyces cerevisiae to any of the known ATP-depend-
ent DAG kinases in bacteria or higher eukaryotes (22, 23), a
previous report showed that PA is produced frommembrane
lipids using CTP as a phosphate donor (24). This, coupled
with the fact that Dgk1p contains a CTP transferase domain,
prompted us to test whether Dgk1p could be a CTP-depend-
ent DAG kinase (25). We measured DAG kinase activity in
extracts derived from wild-type, dgk1, pah1, and pah1
dgk1 cells using [-32P]CTP as a phosphate donor. As
shown in Fig. 5A, the dgk1 mutation alone and in combi-
nation with pah1 resulted in a complete loss of the activity
catalyzing the formation of PA from DAG and CTP. This
result indicated that DGK1 encodes a DAG kinase activity.
To confirm this, Dgk1p was partially purified as a PtA-Dgk1p
fusion over an IgG-Sepharose column, followed by removal
of the PtA tag by tobacco etch virus protease cleavage, and
assayed for DAG kinase activity (Fig. 5B). The purified pro-
tein catalyzed a dose- and time-dependent phosphorylation
of DAG using CTP as a phosphate donor (Fig. 5B). Taken
together, these data show that Dgk1p is a novel CTP-de-
pendent DAG kinase enzyme. The fact that Dgk1p uses CTP,
rather than ATP, as a phosphate donor, explains why it does
FIGURE 3.DGK1 opposes the function of PAH1 at the nuclear membrane.
A, overexpression of DGK1 causes nuclear/ER membrane proliferation and
nuclear expansion. The RS453 strain expressing the plasmid-borne SEC63-
GFP and RFP-PUS1 reporters was transformed with a centromeric plasmid
expressing DGK1 under the control of a galactose-inducible promoter or an
empty vector. Cells were grown in galactose-containing medium and visual-
ized by confocal microscopy. Scale bar 5 m. B, deletion of DGK1 restores
normal nuclear structure in pah1 cells. Wild-type RS453, pah1, and pah1
dgk1 cells transformed with a centromeric plasmid expressing SEC63-GFP
were visualized by confocal microscopy. Scale bar 5 m.
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not show homology to any of the previously described DAG
kinases from other species. The enzymological properties of
this novel enzyme are described in the accompanying article
(25).
Dgk1p-derived PA Accumulates on the Nuclear Membrane—
Next, we asked whether the DAG kinase activity of Dgk1p is
responsible for nuclear/ER membrane growth. The CTP
transferase domain of Dgk1p exhibits significant similarity
to the corresponding domain of cytidylyltransferases, pre-
sumably because both need to bind to CTP for catalysis.
Multiple sequence alignment of Dgk1p with cytidylyltrans-
ferases from many species identified an aspartate residue
(Asp177) within its catalytic domain that is essentially con-
served in all cytidylyltransferases examined (Fig. 6A). A
dgk1 strain expressing a mutant DGK1 allele in which this
residue was changed to alanine (DGK1(D177A)) did not dis-
play any CTP-dependent DAG kinase activity (Fig. 6B) and,
unlike wild-type DGK1, did not trigger nuclear/ER mem-
brane expansion in galactose medium (Fig. 6C). Therefore,
the DAG kinase activity of Dgk1p is responsible for nuclear
membrane expansion.
If the DAG kinase activity of Dgk1p causes nuclear expan-
sion, then one would expect that PA levels in intracellular
membranes would rise following the induction of Dgk1p. To
FIGURE4.DeletionofDGK1 restoresnormalPAand INO1 transcript levels in
pah1 cells. A, phospholipid composition of wild-type, dgk1, pah1, and
pah1 dgk1 cells in the exponential phase of growth. The indicated yeast
strains were grown to exponential phase in the presence of 32Pi (10 Ci/ml).
Phospholipidswereextractedandseparatedbytwo-dimensional thin layerchro-
matography. Images of 32P-labeled phospholipids were visualized by phospho-
rimagingand subjected to ImageQuant analysis. Thepercentages shown for the
individual phospholipids were normalized to the total 32P-labeled chloroform-
soluble fraction that included sphingolipids and unidentified phospholipids.
Each data point represents the mean S.D. of three experiments. PI, phospha-
tidylinositol; PS, phosphatidylserine. B, neutral lipid composition of wild-type,
dgk1, pah1, and pah1 dgk1 cells in the stationary phase of growth. The
indicated yeast strains were grown to stationary phase in the presence of
[2-14C]acetate (1 Ci/ml). Lipids were extracted and separated by one-dimen-
sional thin layer chromatography. Imagesof 14C-labeled lipidswerevisualizedby
phosphorimaging and subjected to ImageQuant analysis. The percentages
shown for the individual lipids were normalized to the total 14C-labeled chloro-
form-soluble fraction.Eachdatapoint represents themeanS.D.of threeexper-
iments. TAG, triacylglycerol; Erg, ergosterol; ErgE, ergosterol ester; FA, fatty acid;
PL, phospholipid. C, INO1 mRNA levels of wild-type, pah1, dgk1, and pah1
dgk1 cells. ThemRNA levels of INO1wereanalyzed in the indicatedstrainsgrown
inYEPDmediumbyquantitativereal-timereversetranscription-PCR.Amplificationof
each samplewasperformed induplicate andnormalized toRTG2. Values anderrors
were calculated fromthree independent experiments. Values are expressedas -fold
derepressionover thevaluesmeasured in thewild-typestrain.
FIGURE 5. Dgk1p is a novel CTP-dependent DAG kinase. A, the dgk1
mutation abolishes diacylglycerol kinase activity. Cell extracts were prepared
from wild-type, dgk1, pah1, and pah1 dgk1 cells at the exponential
phase of growth, and 50g of protein from each cell extract was assayed for
diacylglycerol kinase activity. Left panel, the 32P-labeled reaction productwas
extracted with chloroform, separated by thin layer chromatography using a
solvent system of chloroform/methanol/water (65:25:4), and visualized by
phosphorimaging. Right panel, the 32P-labeled reaction product was
extractedwith chloroformand subjected to liquid scintillation counting. Each
data point represents the mean S.D. of triplicate enzyme determinations.
B, Dgk1p exhibits DAG kinase activity. The DAG kinase activity of partially
purified Dgk1p was measured with the indicated protein content (left panel)
and for the indicated time intervals (right panel).
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visualize the intracellular location of PA accumulation, we
followed the distribution of a GFP fusion of a short domain
of the t-SNARE (target membrane soluble N-ethylmaleim-
ide-sensitive factor attachment protein receptor) Spo20p
(GFP-Spo20p-(51–91)). This GFP fusion is responsive to
changes in PA levels in vivo and has been used previously as
a PA sensor in both yeast (26) and mammalian (27) cells.
Cells expressing GFP-Spo20p-(51–91) were transformed
with either an empty vector or a GAL1/10-driven DGK1
plasmid and transferred into galactose-containing medium.
Consistent with previous data (26), in control cells, GFP-
Spo20p-(51–91) was found at the plasma membrane (Fig.
7A). When cells carrying GAL-DGK1 were transferred into
galactose medium, the PA sensor relocalized to internal
membranes (Fig. 7B). Interestingly, in the majority of these
cells (79% of the cells with internal membrane staining), the
PA-enriched membranes formed around the irregularly
shaped nucleus and often extended into the cytoplasm (Fig.
7B). Overexpression of bacterial Dgk1p, which has been
shown to relocalize to internal membranes in yeast (26),
resulted in a similar relocation of the PA sensor to the
nuclear membrane.4 Taken together, these results indicate
that Dgk1p-produced PA accumulates on intracellular
membranes around the nucleus.
Dgk1p Regulates Nuclear Membrane but Not Cortical ER
Membrane Proliferation—Wenext asked whether the high lev-
els of PA produced by Dgk1p cause membrane proliferation of
both ER subcompartments, viz. the cortical ER and the perinu-
clear ER or nuclear membrane. To address this question, we
used aGFP fusion of Rtn2p, amember of the reticulon family of
integral membrane proteins that, unlike other ER proteins like
Sec63p, localize exclusively to the cortical ER (28, 29). To label
the nuclearmembrane, we expressed aGFP fusion ofHeh2p, an
integral inner nuclear membrane protein that does not diffuse
to the cortical ER (30). When cells carrying GAL-DGK1 were
grown under non-inducing conditions (Fig. 8A), neither the
nuclear nor cortical ER was affected.4 Induction of Dgk1p pro-
duction for 5 h led to irregularly shaped nuclei, often containing
one nuclear membrane projection extending into the cyto-
plasm (Fig. 8B). After 9 h, nuclear expansion was more evident,
leading to many cells with two expanded interconnected
nuclear compartments. Interestingly, at both time points, no
apparent proliferation of the cortical ER membrane was seen.
The overall cortical (Fig. 8C, upper panels) and reticular (lower
panels) membrane staining of Rtn2p-GFP was not significantly
altered in the Dgk1p-overexpressing cells compared with the
control cells. Therefore, elevated PA levels, generated by the
overexpression ofDgk1p, causes proliferation of themembrane
of the nuclear but not cortical ER.
Lack of Biosynthetic PA Enzymes Restores Nuclear Struc-
ture in pah1 Cells—If the decrease in PA is responsible for
restoring a normal nucleus in the pah1 dgk1mutant, then
other mutations that are known to decrease the rate of the de
novo synthesis of PA should have a similar compensatory
effect in pah1 cells. To test this hypothesis, we deleted the
redundant acyltransferase genes GAT1 and GAT2, previ-
ously shown to be required for PA production (Ref. 31; see
also Fig. 1A), in the pah1mutant. The pah1 gat2 double
mutant grew better than the pah1 mutant at both 30 and
FIGURE 6. The DAG kinase activity of Dgk1p is required for nuclear
membrane expansion. A, multiple sequence alignment of Dgk1p (resi-
dues 162–182) with cytidylyltransferases from the indicated species. The
first residue of each sequence segment is indicated. The arrow points to
the conserved aspartate residue. B, the DGK1(D177A) mutant lacks DAG
kinase activity. The dgk1 strain was transformed with an empty centro-
meric plasmid or with the same plasmid carrying DGK1 or DGK1(D177A)
under the control of the GAL1/10 promoter. Cell extracts from the corre-
sponding strains were assayed for diacylglycerol kinase activity. Values
and errors were calculated from three experiments. C, DGK1(D177A) does
not promote nuclear membrane growth. The RS453 strain expressing a
SEC63-GFP fusion was transformed with the galactose-inducible DGK1 or
DGK1(D177A) construct from B, grown to early logarithmic phase in galac-
tose-containing medium, and inspected by microscopy.
FIGURE 7. Overexpression of Dgk1p causes relocation of a PA-binding
reporter at the nuclear membrane. The RS453 strain expressing the
mCherry-PUS1 fusion and the GFP-SPO20-(51–91) reporter was transformed
with a 2 vector (A) or the same vector carryingDGK1 (B). Cells were grown in
raffinose, transferred into galactose-containing medium for 6 h, and viewed
by confocal microscopy. Scale bar 5 m.
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37 °C (Fig. 9A) and exhibited a 50% decrease in the tran-
scriptional derepression of the INO1 gene as measured by
quantitative reverse transcription-PCR (Fig. 9B). This epi-
static effect is due to the lack of Gat2p enzymatic activity,
required for PA production, because it can be reproduced
using a mutant (G253L) that is predicted to be catalytically
dead (Fig. 9C) (32). Notably, the nuclear structure in pah1
cells lacking Gat2p activity was significantly improved com-
pared with the pah1 cells (Fig. 9D). Therefore, inhibition of
upstream steps that reduce PA synthesis is sufficient to
decrease the membrane proliferation defects of pah1 cells.
We next analyzed the effect of inhibiting steps downstream
of the PA phosphatase reaction, leading to the production of
PE (pah1 psd1) or PC (pah1 cho2 and pah1 opi3) in
pah1 cells. Interestingly, we found that the pah1 psd1
double mutant is synthetically lethal (Fig. 9E), possibly
because of the simultaneous inhibition of both the CDP-
DAG (due to psd1) and Kennedy (due to pah1) pathways
of phospholipid biosynthesis. Unlike pah1 gat2, neither
the pah1 cho2 nor pah1 opi3 mutant exhibited
improved growth (Fig. 9E) or nuclear membrane structure.4
Taken together, these data indicate that high PA levels are a
major trigger for the nuclear membrane proliferation in
yeast cells.
DISCUSSION
How phospholipids impact on organelle structure remains
largely unknown. In this work, we have shown that PA homeo-
stasis is a critical factor controlling nuclear structure in yeast. In
two genetic screens looking for novel regulators of PA metab-
olism, we identified Dgk1p, the first DAG kinase described in
yeast. Dgk1p-driven overproduction of PA at the nuclearmem-
brane causes nuclear expansion, without proliferating cortical
ER membrane. Thus, the modulation of Dgk1p activity offers a
uniquemodel system to study the regulation of nuclear growth.
Dgk1p Is a Novel CTP-dependent DAG Kinase—DAG kinase
enzymes have been identified in almost all organisms exam-
ined, including bacteria, plants, worms, flies, andmammals. All
DAG kinases have a catalytic domain that contains an ATP-
binding sitewith the sequenceGXGXXGthat is essential for the
kinase reaction (22, 23). Dgk1p is an unconventional DAG
kinase that uses CTP, instead of ATP, as a phosphate donor and
therefore does not exhibit sequence similarity to DAG kinases
from other species. Furthermore, Dgk1p contains a short motif
recently identified in a family of CTP-dependent phytol and
dolichol kinases (33)4. Although the significance of this differ-
ence betweenDgk1p and the otherDAGkinases is not yet clear,
it could have important physiological implications. Previous
studies have established that elevated levels of cytosolic CTP
(due to a defect in CTP feedback inhibition of CTP synthase)
lead to increased PA levels, derepression of INO1, and the ino-
sitol excretion phenotype (34). Our data raise the possibility
that this regulation ismediated by the CTP-driven activation of
Dgk1p.
Regulation of PA Homeostasis by Dgk1p—The genetic inter-
actions betweenDGK1 and PAH1 fit well with the biochemical
data on the activity of Dgk1p. Overexpression of a hyperactive
Pah1p mutant decreases cellular PA by converting it to DAG,
causing the PA-dependent repression of phospholipid biosyn-
thetic genes by Opi1p, and results in inositol auxotrophy (11).
This lethality can be rescued by the overexpression of Dgk1p,
which catalyzes the reverse reaction and restores PA levels. The
fact that the deletion of DGK1 in pah1 cells returns PA levels
to normal could indicate that, in wild-type cells, Dgk1p pro-
duces some of the ER pools of PA that are accessible to Pah1p.
Although the dgk1mutation returns the levels of the other
abundant phospholipids, PC and PE, almost to normal in
pah1 cells, it does not change the defects in phosphatidylino-
sitol and triacylglycerol levels. The fact that dgk1 pah1 cells
have completely normal nuclear structure but still exhibit
growth defects at 30 °C and are temperature-sensitive at 37 °C,
like pah1 cells, suggests that PA and/or PC and PE are respon-
sible for the effects on the nuclear membrane, whereas phos-
phatidylinositol and triacylglycerol levels contribute more to
the toxicity of pah1 cells.
FIGURE 8. Overexpression of Dgk1p causes proliferation of the nuclear
membrane but not cortical ER membrane. A, shown is the time course of
the induction of DGK1-PtA. Wild-type cells (RS453) expressing DGK1-PtA
under the control of the GAL1/10 promoter in a centromeric plasmid were
transferred from raffinose to galactose-containing medium, and protein
extracts were prepared at the indicated time points. Protein samples were
resolved by SDS-PAGE followed by Western blotting using anti-PtA antibod-
ies. B, cells expressing anHEH2-GFP fusion andDGK1 under the control of the
GAL1/10 promoter in a centromeric plasmid were transferred from raffinose
to galactose-containingmedium for the indicated times. Heh2p-GFP labeling
(upper panels) or cell/Heh2p-GFP overlays (lower panels) were visualized at
the indicated timepointsby confocalmicroscopy.C, cells expressinganRTN2-
GFP fusion and DGK1 under the control of the GAL1/10 promoter in a centro-
meric plasmid were transferred from raffinose to galactose-containing
medium for the indicated times. Upper panels, confocal Z-sections corre-
sponding to the cell center; lower panels, confocal sections corresponding to
the cell periphery. Scale bars 5 m.
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Interestingly, not all enzymes involved in the production of
PA can rescue pah1 when removed. Although deletion of
either Gat1p or Gat2p ER acyltransferases has been shown pre-
viously to significantly reduce cellular PA levels (31), only gat2
can partially rescue the pah1 defects. The fact that these two
enzymes have distinct fatty acyl substrate specificities (31)
raises the intriguing possibility that different PA pools, with
respect to acyl chain length and/or saturation, could have dif-
ferent physiological effects. Alternatively, differences in the
effects of the gat1 and gat2 mutations in lipid synthesis
downstream of PA (35) could also contribute to their differen-
tial rescue of pah1 cells.
A Role for PA Metabolism in Nuclear Structure—Overex-
pression of certain transmembrane enzymes involved in lipid
biosynthesis, such as hydroxymethylglutaryl-CoA and cyto-
chrome b5, induces membrane biogenesis in the form of kar-
mellae, stacks of proliferated ER wrapped around the nucleus
(36, 37). In both cases, ER membrane proliferation could be
induced even when the catalytically inactive proteins were
overexpressed (37, 38), indicating that, unlike Dgk1p, mem-
brane proliferation in these cells is not a direct consequence of
changes in lipid composition but rather a response to accom-
modate the excess transmembrane proteins.
Here, we have shown that the DAG kinase activity of Dgk1p
is responsible for nuclearmembrane proliferation.HighPA lev-
els can have two distinct effects on lipid homeostasis andmem-
brane biogenesis that could be responsible for nuclear growth.
First, PA acts as a signal that dere-
presses transcription of key
enzymes of the CDP-DAG pathway
(Fig. 1A), which provide bulk phos-
pholipids for membrane formation.
Indeed, transcriptional derepres-
sion of these enzymes is necessary
for nuclear membrane proliferation
in pah1 cells (10). However, con-
stitutive overexpression of the bio-
synthetic enzymes in cells lacking
the repressor OPI1 does not lead to
nuclear membrane expansion, sug-
gesting that, apart from the dere-
pression of lipid synthesis in the ER,
other events contribute to nuclear
membrane expansion (11). The sec-
ond effect of PA on membranes is
due to its conical structure and its
bending functions that are impli-
cated in many remodeling events
like membrane budding and fission.
Changes in the physical properties
of the double bilayered nuclear
membrane could contribute to its
expansion. Interestingly, a role for
membrane tubulation in nuclear
membrane expansion has been
described recently in tissue cultured
cells in which expression of mem-
brane-deforming mutants of CTP-
phosphocholine cytidylyltransferase- causes nuclear mem-
brane proliferation (39, 40).
The distinct functions of Dgk1p-driven PA production in the
nuclear envelope are also underscored by the fact that overpro-
duction of Dgk1p does not appear to significantly induce corti-
cal ER membrane proliferation, as visualized using a reticulon-
GFP fusion. This raises the intriguing question of whether PA
and downstream-derived phospholipids are differentially pro-
cessed in the two subcompartments or whether active Dgk1p
concentrates preferentially on the nuclear membrane. Given
the significant changes that yeast nuclei undergo during cell
division, the temporal and spatial regulation of PAmetabolism
by Dgk1p and Pah1p could play crucial roles in this process.
Future studies will further address the role of Dgk1p in nuclear
structure and phospholipid biosynthesis.
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